Makoto Mark Taketo

Dr. Makoto Mark Taketo

Division of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo, Kyoto 606-8501, Japan
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
KAKoji Aoki
Koji Aoki
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo
The adenomatous polyposis coli (APC) gene is a key tumor suppressor gene. Mutations in the gene have been found not only in most colon cancers but also in some other cancers, such as those of the liver. The APC gene product is a 312 kDa protein that has multiple domains, through which it binds to various proteins, including β-catenin, axin, CtBP, Asefs, IQGAP1, EB1 and microtubules. Studies using mutant mice and cultured cells have demonstrated that APC suppresses canonical Wnt signalling, which is essential for tumorigenesis, development and homeostasis of a variety of cell types, such as epithelial and lymphoid cells. Further studies have suggested that APC plays roles in several other fundamental cellular processes. These include cell adhesion and migration, organization of the actin and microtubule networks, spindle formation and chromosome segregation. Deregulation of these processes caused by mutations in APC is implicated in the initiation and expansion of colon cancer.

1 June 2004 in Cancer Research
Verified
Journal Article
Closed access
PDF file
KKKenji Kawada
Kenji Kawada
MSMasahiro Sonoshita
Masahiro Sonoshita
HSHiromi Sakashita
Hiromi Sakashita
ATArimichi Takabayashi
Arimichi Takabayashi
YYYoshio Yamaoka
Yoshio Yamaoka
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo
Chemokines and their receptors play key roles in leukocyte trafficking and are also implicated in cancer metastasis to specific organs. Here we show that mouse B16F10 melanoma cells constitutively express chemokine receptor CXCR3, and that its ligands CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC induce cellular responses in vitro, such as actin polymerization, migration, invasion, and cell survival. To determine whether CXCR3 could play a role in metastasis to lymph nodes (LNs), we constructed B16F10 cells with reduced CXCR3 expression by antisense RNA and investigated their metastatic activities after s.c. inoculations to syngeneic hosts, C57BL/6 mice. The metastatic frequency of these cells to LNs was markedly reduced to ∼15% (P < 0.05) compared with the parental or empty vector-transduced cells. On the other hand, pretreatment of mice with complete Freund’s adjuvant increased the levels of CXCL9 and CXCL10 in the draining LNs, which caused 2.5–3.0-fold increase (P < 0.05) in the metastatic frequency of B16F10 cells to the nodes with much larger foci. Importantly, such a stimulation of metastasis was largely suppressed when CXCR3 expression in B16F10 cells was reduced by antisense RNA or when mice were treated with specific antibodies against CXCL9 and CXCL10. We also demonstrate that CXCR3 is expressed on several human melanoma cell lines as well as primary human melanoma tissues (5 of 9 samples tested). These results suggest that CXCR3 inhibitors may be promising therapeutic agents for treatment of LN metastasis, including that of melanoma.

1 March 2009 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo
WEWinfried Edelmann
Winfried Edelmann

5 February 2007 in Oncogene
Verified
Journal Article
Closed access
KKK Kawada
K Kawada
HHH Hosogi
H Hosogi
MSM Sonoshita
M Sonoshita
HSH Sakashita
H Sakashita
TMT Manabe
T Manabe
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo

11 March 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
HOHiroko Oshima
Hiroko Oshima
MOMasanobu Oshima
Masanobu Oshima
KIKayo Inaba
Kayo Inaba
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo
Cyclooxygenase‐2 (COX‐2), the rate‐limiting enzyme for prostanoid biosynthesis, plays a key role in gastrointestinal carcinogenesis. Among various prostanoids, prostaglandin E2 (PGE2) appears to be most responsible for cancer development. To investigate the role of PGE2 in gastric tumorigenesis, we constructed transgenic mice simultaneously expressing COX‐2 and microsomal prostaglandin E synthase (mPGES)‐1 in the gastric epithelial cells. The transgenic mice developed metaplasia, hyperplasia and tumorous growths in the glandular stomach with heavy macrophage infiltrations. Although gastric bacterial counts in the transgenic mice were within the normal range, treatment with antibiotics significantly suppressed activation of the macrophages and tumorous hyperplasia. Importantly, the antibiotics treatment did not affect the macrophage accumulation. Notably, treatment of the transgenic mice with lipopolysaccharides induced proinflammatory cytokines through Toll‐like receptor 4 in the gastric epithelial cells. These results indicate that an increased level of PGE2 enhances macrophage infiltration, and that they are activated through epithelial cells by the gastric flora, resulting in gastric metaplasia and tumorous growth. Furthermore, Helicobacter infection upregulated epithelial PGE2 production, suggesting that the COX‐2/mPGES‐1 pathway contributes to the Helicobacter ‐associated gastric tumorigenesis.

1 January 2004 in Cancer Research
Verified
Journal Article
Open access
PDF file
NHNaomoto Harada
Naomoto Harada
HOHiroko Oshima
Hiroko Oshima
MKMasahiro Katoh
Masahiro Katoh
YTYositaka Tamai
Yositaka Tamai
MOMasanobu Oshima
Masanobu Oshima
Makoto Mark TaketoMakoto Mark Taketo
Makoto Mark Taketo
We have established previously a mouse strain containing a mutant β-catenin allele of which exon 3 was sandwiched by loxP sequences [Catnblox(ex3)]. In this mouse strain, a Wnt-activating β-catenin mutation alone is insufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required. Here we report that hepatocellular carcinoma develops at the 100% incidence in mice with simultaneous mutations in the β-catenin and H-ras genes that are introduced by adenovirus-mediated Cre expression. Although H-ras mutation alone rapidly causes large cell dysplasia in the hepatocytes, these cells show no autonomous growth within 1 week after infection of the Cre-adenovirus. However, simultaneous induction of an additional mutation in the β-catenin gene causes a clonal expansion of such dysplastic cells, followed by nodular formation and development of hepatocellular carcinoma. These results indicate that β-catenin mutations play a critical role in hepatocarcinogenesis in cooperation with another oncogene and that these mice provide a convenient model to investigate early steps of hepatocarcinogenesis.